Nephrology

Stress-Related Disorders May Increase CKD Progression, AKI Risk

Publish Date February 10, 2021

Individuals diagnosed with a stress-related disorder may warrant increased surveillance of their kidney function, according to study investigators.

Inflammatory Bowel Disease in IgAN Linked to Increased Kidney Failure Risk

Publish Date February 9, 2021

A past or present diagnosis of inflammatory bowel disease elevates the risk of progression to kidney failure among patients with IgA nephropathy, according to investigators.

Dialysis Providers Push for Direct Allocation of COVID-19 Vaccines

Publish Date February 8, 2021

Dialysis facilities would be more successful at immunizing patients against the COVID-19 coronavirus if they receive direct allocations of the vaccine, according to officials from major dialysis companies.

Urine-to-Plasma Urea Ratio Predicts ADPKD Progression

Publish Date February 5, 2021

The early morning fasting urine-to-plasma urea ratio reflects the kidneys’ urine-concentrating capacity, which may decline early in ADPKD, according to investigators.

Removing Race From eGFR Calculations Ups CKD Prevalence Among Black Patients

Publish Date February 1, 2021

Nearly a million more Black adults in the United States would have stage 3 chronic kidney disease if the race coefficient were removed from the CKD-EPI equation used to estimate glomerular filtration rate, according to an analysis.

Renal Insufficiency May Worsen Multiple Myeloma Outcomes

Publish Date January 27, 2021

Risk for disease progression or death increased for those with renal insufficiency in relapsed/refractory, newly diagnosed MM

Death Rate in the Dialysis Population Surges With COVID-19

Publish Date January 25, 2021

A study revealed a nearly 25% rate of all-cause mortality among patients on maintenance dialysis who contract COVID-19.

Dialysis Use by Older Patients Varies Widely Across VA Facilities

Publish Date January 22, 2021

Dialysis use among older Veterans Affairs (VA) patients with incident kidney failure varied from 25.0% to 81.4% across 108 VA facilities, a study found.

First Treatment for Newly Diagnosed Light Chain Amyloidosis Approved

Publish Date January 21, 2021

The approval was based on data from the open-label, active-controlled phase 3 ANDROMEDA study.

Therapeutic Advances in Kidney Failure Care Linked to Improved Survival

Publish Date January 20, 2021

Study results show that mortality among hemodialysis patients declined from 2006 to 2015 compared with the general Swedish population.